Covered recipient · General Payments record
ALEXANDRA L RUBENSTEIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$827.92
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.99 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $160.67 | 2 |
| ANI Pharmaceuticals, Inc. | $85.40 | 1 |
| Inspire Medical Systems, Inc. | $25.74 | 1 |
| Lilly USA, LLC | $19.61 | 1 |
| Novo Nordisk AS | $19.57 | 1 |
| SHIELD THERAPEUTICS INC | $17.47 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.94 | 1 |
| Gilead Sciences, Inc. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | $85.40 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091151176 | CMS |
| AstraZeneca Pharmaceuticals LP | $51.87 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104557732 | CMS |
| AstraZeneca Pharmaceuticals LP | $108.80 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105771894 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.94 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118151139 | CMS |
| Gilead Sciences, Inc. | $15.59 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668866 | CMS |
| Inspire Medical Systems, Inc. | $25.74 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148167277 | CMS |
| Lilly USA, LLC | $19.61 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135497870 | CMS |
| Novo Nordisk Inc | $19.57 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100514901 | CMS |
| SHIELD THERAPEUTICS INC | $17.47 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150134601 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.